About 2,2,6-trimethyl-3-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydrochromen-4-amine
2,2,6-trimethyl-3-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydrochromen-4-amine (PubChem CID 82188315) has the molecular formula C18H29N3O
and a molecular weight of 303.45 g/mol. Its IUPAC name is 2,2,6-trimethyl-3-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydrochromen-4-amine.
Analyze 2,2,6-trimethyl-3-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydrochromen-4-amine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2,2,6-trimethyl-3-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydrochromen-4-amine?
The IUPAC name of 2,2,6-trimethyl-3-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydrochromen-4-amine (CID 82188315) is 2,2,6-trimethyl-3-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydrochromen-4-amine.
What is the SMILES notation for 2,2,6-trimethyl-3-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydrochromen-4-amine?
The canonical SMILES for 2,2,6-trimethyl-3-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydrochromen-4-amine is Cc1ccc2c(c1)C(N)C(CN1CCN(C)CC1)C(C)(C)O2.
What is the InChIKey of 2,2,6-trimethyl-3-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydrochromen-4-amine?
The InChIKey is VOFYYONSSWCMBE-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H29N3O/c1-13-5-6-16-14(11-13)17(19)15(18(2,3)22-16)12-21-9-7-20(4)8-10-21/h5-6,11,15,17H,7-10,12,19H2,1-4H3.
What are the key properties of 2,2,6-trimethyl-3-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydrochromen-4-amine?
2,2,6-trimethyl-3-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydrochromen-4-amine has a molecular weight of 303.45 g/mol, XLogP of 2.03, 2 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2,2,6-trimethyl-3-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydrochromen-4-amine is sourced from PubChem (CID 82188315), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).